Develops innovative products for the treatment of cardiovascular diseases
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SAGCX | 47.89 | 0.21 | +0.44% |
ClearBridge Growth C | |||
MMIAX | 8.02 | N/A | N/A |
MassMutual International Eq A | |||
PXNIX | 10.57 | -0.08 | -0.75% |
Impax International Sust Econ Instl | |||
BGPFX | 12.78 | -0.10 | -0.79% |
Baillie Gifford Developed EAFE All Cap 3 | |||
RPMYX | 11.59 | -0.14 | -1.19% |
Reinhart International PMV Advisor |
A.I.dvisor tells us that CAPR and SRPT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CAPR and SRPT's prices will move in lockstep.
Ticker / NAME | Correlation To CAPR | 1D Price Change % | ||
---|---|---|---|---|
CAPR | 100% | -2.64% | ||
SRPT - CAPR | 32% Poorly correlated | +1.05% | ||
MDGL - CAPR | 30% Poorly correlated | +0.47% | ||
FATE - CAPR | 30% Poorly correlated | +4.25% | ||
SLNO - CAPR | 28% Poorly correlated | -2.74% | ||
CORT - CAPR | 27% Poorly correlated | +1.19% | ||
More |